THERAPEUTIC AGENTS FOR OCULAR INFLAMMATORY DISEASE COMPRISING INTERLEUKIN 6 RECEPTOR INHIBITOR AS ACTIVE INGREDIENT
Application
US20260078193A1
Kind: A1
Mar 19, 2026
Assignee
OSAKA UNIVERSITY
Inventors
Nobuyuki OHGURO, Yasuo TANO, Kohei SONODA, Tatsuro ISHIBASHI
Abstract
The present invention relates to therapeutic and/or prophylactic agents for ocular inflammatory disease, which comprise an interleukin 6 (IL-6) receptor inhibitor as an active ingredient.
CPC Classifications
C07K 16/2866
A61K 31/00
A61K 2039/505
C07K 2317/24
C07K 2317/76
Filing Date
2025-07-25
Application No.
19280879